Mathew Easow Research Securities Limited
BSE: MATHEWE
Prev Close
12.23
Open Price
12.84
Volume
5
Today Low / High
12.84 / 12.84
52 WK Low / High
9.21 / 13.24
Range
12 - 13
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 12.84, reflecting a change of 0.61 (4.98774%). The expected target range on the BSE is 12 - 13. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Mathew Easow Research Securities Limited Graph
Mathew Easow Research Securities Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Mathew Easow Research Securities Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 12.84, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 12.84 | 12.97 | 11.67 - 14.27 |
| 13.10 | 10.48 - 15.72 | ||
| 13.23 | 9.26 - 17.19 | ||
| Bearish Scenario | 12.84 | 12.71 | 11.44 - 13.98 |
| 12.58 | 10.07 - 15.10 | ||
| 12.45 | 8.72 - 16.19 |
Overview of Mathew Easow Research Securities Limited
ISIN
INE963B01019
Industry
Investment - Banking & Investment Services
Vol.Avg
164
Market Cap
85,386,000
Last Dividend
0
Official Website
IPO Date
2000-11-27
DCF Diff
-22.37
DCF
35
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.67 Cr | 0.01 Cr | 2.65 Cr | 0.9927 | 0.00 Cr | 0.30 Cr | 1.74 Cr | 0.08 Cr | 0.12 | 1.75 Cr | 0.0311 |
| 2024-03-31 | 14.47 Cr | 14.00 Cr | 0.47 Cr | 0.0323 | 0.00 Cr | 0.01 Cr | 0.11 Cr | 0.06 Cr | 0.09 | 0.13 Cr | 0.0042 |
| 2023-03-31 | 2.47 Cr | 1.84 Cr | 0.47 Cr | 0.1894 | 0.00 Cr | 0.02 Cr | 1.77 Cr | 0.04 Cr | 0.07 | 1.79 Cr | 0.0180 |
| 2022-03-31 | 2.44 Cr | 1.71 Cr | 0.85 Cr | 0.3465 | 0.00 Cr | 0.24 Cr | 0.74 Cr | 0.11 Cr | 0.16 | 0.80 Cr | 0.0431 |
| 2021-03-31 | 2.19 Cr | 1.00 Cr | 1.20 Cr | 0.5454 | 0.00 Cr | 0.44 Cr | 0.84 Cr | 0.11 Cr | 0.17 | 0.94 Cr | 0.0502 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.06 Cr | 36.35 Cr | 22.17 Cr | 14.1782 Cr | 21.98 Cr | 21.92 Cr | 0.00 Cr | 0.08 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.1723 Cr |
| 2024-03-31 | 0.04 Cr | 37.46 Cr | 23.36 Cr | 14.0954 Cr | 46.51 Cr | 46.47 Cr | 0.02 Cr | 0.10 Cr | 0.00 Cr | 0.00 Cr | 0.09 Cr | 23.3646 Cr |
| 2023-03-31 | 0.17 Cr | 46.03 Cr | 31.99 Cr | 14.0351 Cr | 63.91 Cr | 31.79 Cr | 12.02 Cr | 0.11 Cr | 0.00 Cr | 31.99 Cr | -0.12 Cr | 31.9899 Cr |
| 2022-03-31 | 0.08 Cr | 48.42 Cr | 34.43 Cr | 13.9905 Cr | 68.44 Cr | 34.14 Cr | 12.03 Cr | 0.13 Cr | 0.00 Cr | 34.43 Cr | -0.15 Cr | 34.4283 Cr |
| 2021-03-31 | 0.14 Cr | 45.64 Cr | 31.76 Cr | 13.8853 Cr | 62.48 Cr | 31.10 Cr | 12.03 Cr | 0.25 Cr | 0.00 Cr | 31.76 Cr | -0.12 Cr | 31.6773 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.4742 Cr | 0.8181 Cr | -1.2710 Cr | 0.0000 Cr | 0.0213 Cr | 0.0604 Cr | 0.0000 Cr | 0.0830 Cr | -1.2710 Cr | 0.0000 Cr | 0.0000 Cr |
| 2024-03-31 | 10.3770 Cr | 0.0160 Cr | -10.5218 Cr | 12.4226 Cr | -0.1288 Cr | 0.0391 Cr | 0.0000 Cr | 0.0602 Cr | -8.6990 Cr | 0.0000 Cr | 12.0000 Cr |
| 2023-03-31 | 4.0554 Cr | 0.0071 Cr | -3.9712 Cr | 4.0554 Cr | 0.0913 Cr | 0.1679 Cr | 0.0000 Cr | 0.0637 Cr | -2.2657 Cr | 0.0000 Cr | 0.0077 Cr |
| 2022-03-31 | -2.5558 Cr | 1.1061 Cr | 1.3855 Cr | -2.5558 Cr | -0.0642 Cr | 0.0766 Cr | 0.0000 Cr | 0.1802 Cr | 2.9804 Cr | 0.0000 Cr | 0.0000 Cr |
| 2021-03-31 | -0.0979 Cr | -0.0050 Cr | 14.6064 Cr | -0.1033 Cr | 14.5035 Cr | 14.8712 Cr | -0.0054 Cr | 0.0925 Cr | 15.3517 Cr | 0.0000 Cr | -9.5283 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 0.72 Cr | 0.48 Cr | 0.23 Cr | 0.3267 | 0.01 Cr | 0.01 Cr | 0.01 | 0.02 Cr | 0.0120 |
| 2025-09-30 | 0.83 Cr | 0.39 Cr | 0.44 Cr | 0.5316 | 0.03 Cr | 0.02 Cr | 0.04 | 0.04 Cr | 0.0290 |
| 2025-06-30 | 0.72 Cr | 0.32 Cr | 0.40 Cr | 0.5520 | 0.03 Cr | 0.02 Cr | 0.03 | 0.03 Cr | 0.0322 |
| 2025-03-31 | 0.61 Cr | 0.38 Cr | 0.23 Cr | 0.3790 | 0.02 Cr | 0.02 Cr | 0.02 | 0.02 Cr | 0.0263 |
| 2024-12-31 | 0.83 Cr | 0.68 Cr | 0.15 Cr | 0.1803 | 1.72 Cr | 0.02 Cr | 0.03 | 0.03 Cr | 0.0211 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 0.17 Cr | 0.00 Cr | 0.17 Cr | 0.00 Cr | 0.00 Cr | 35.90 Cr | 0.08 Cr | 36.08 Cr | 21.86 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -14.18 Cr |
| 2025-03-31 | 0.06 Cr | 0.00 Cr | 0.06 Cr | 0.00 Cr | 0.00 Cr | 36.16 Cr | 0.08 Cr | 36.35 Cr | 22.17 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -14.14 Cr |
| 2024-09-30 | 0.07 Cr | 0.00 Cr | 0.07 Cr | 0.00 Cr | 0.02 Cr | 40.32 Cr | 0.09 Cr | 40.56 Cr | 26.42 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.02 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 0.02 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 0.02 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.03 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.02 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Investment - Banking & Investment Services
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Medi Assist Health Ser L | MEDIASSIST | ₹386.85 | ₹28,803,976,719.00 | ₹175,584.00 |
Key Executives
Gender: male
Year Born: 1972
Gender: female
Year Born:
FAQs about Mathew Easow Research Securities Limited
The CEO is Beda Nand Choudhary.
The current price is ₹12.84.
The range is ₹9.21-13.24.
The market capitalization is ₹8.54 crores.
The P/E ratio is 153.58.
The company operates in the Financial Services sector.
Overview of Mathew Easow Research Securities Limited (ISIN: INE963B01019) is a leading Investment - Banking & Investment Services in India. With a market capitalization of ₹8.54 crores and an average daily volume of 164 shares, it operates in the Investment - Banking & Investment Services. The company last declared a dividend of ₹0.